Right axillary artery cannulation for venoarterial extracorporeal membrane oxygenation: a retrospective single centre observational study.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
13 04 2021
Historique:
received: 13 05 2020
revised: 03 09 2020
accepted: 11 09 2020
pubmed: 15 12 2020
medline: 2 7 2021
entrez: 14 12 2020
Statut: ppublish

Résumé

Our goal was to assess the safety, outcomes and complication rate of axillary artery cannulation for venoarterial extracorporeal membrane oxygenation (VA-ECMO). A retrospective analysis was conducted on data obtained from the review of medical charts of all consecutive patients undergoing VA-ECMO implantation between January 2013 and December 2017 at a teaching hospital. Only patients with right axillary VA-ECMO implantation in a non-emergency setting were included. Post-procedural outcomes and local and systemic complications were analysed. One hundred and seventy-four [131 male (75.3%), 43 female (24.7%); mean age 56.8 ± 15.1 years] patients underwent femoral-axillary VA-ECMO. Indications were cardiogenic shock from any cause (n = 78, 44.8%) or post-cardiotomy syndrome (n = 96, 55.2%). Fifty-three (30.5%) patients died while on VA-ECMO support. At the time of VA-ECMO ablation, 89 (51.1%) patients had recovered; 13 (7.5%) patients were bridged to a long-term mechanical support device and 19 (10.9%) patients underwent heart transplants. Thirty-day and 1-year mortality was 36.2% (n = 63) and 49.4% (n = 86), respectively. The 1-year survival rate of patients who were weaned from VA-ECMO support was 72.7% (n = 88). The complications of axillary cannulation were bleeding (n = 7, 4%), local infection (n = 3, 1.7%), upper limb ischaemia (n = 2, 1.1%) and brachial plexus injury (n = 1, 0.6%). Left ventricle unloading was required for 9 (5.2%) patients. The median duration of VA-ECMO support was 7 (range 1-26) days. Right axillary artery cannulation is a safe and reliable method for VA-ECMO support with a low rate of local complications. In the absence of a control group with femoro-femoral cannulation, no definitive conclusion about the superiority of axillary over femoral cannulation can be drawn.

Identifiants

pubmed: 33313742
pii: 6032816
doi: 10.1093/ejcts/ezaa397
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

601-609

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Angelo Pisani (A)

Department of Cardiovascular Surgery, Université de Paris, Bichat-Claude Bernard Hospital, Paris, France.

Wael Braham (W)

Department of Cardiovascular Surgery, Université de Paris, Bichat-Claude Bernard Hospital, Paris, France.

Carlotta Brega (C)

Department of Cardiovascular Surgery, Université de Paris, Bichat-Claude Bernard Hospital, Paris, France.
Maria Cecilia Hospital, GVM Care and Research, Cotignola, Ravenna, Italy.

Moklhes Lajmi (M)

Department of Cardiovascular Surgery, Université de Paris, Bichat-Claude Bernard Hospital, Paris, France.

Sophie Provenchere (S)

Department of Anesthesia, Université de Paris, Bichat-Claude Bernard Hospital, Paris, France.
Université de Paris, Centre d'Investigation Clinique 1425, INSERM, Paris, France.

Pichoy Danial (P)

Department of Cardiovascular Surgery, Université de Paris, Bichat-Claude Bernard Hospital, Paris, France.

Soleiman Alkhoder (S)

Department of Cardiovascular Surgery, Université de Paris, Bichat-Claude Bernard Hospital, Paris, France.

Marylou Para (M)

Department of Cardiovascular Surgery, Université de Paris, Bichat-Claude Bernard Hospital, Paris, France.
Université de Paris, LVTS UMRS 1148, INSERM, Paris, France.

Walid Ghodbane (W)

Department of Cardiovascular Surgery, Université de Paris, Bichat-Claude Bernard Hospital, Paris, France.

Patrick Nataf (P)

Department of Cardiovascular Surgery, Université de Paris, Bichat-Claude Bernard Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH